Quantum-Si

Quantum-Si EBITDA per Share

The EBITDA per Share of Quantum-Si (QSI) as of Nov 10, 2026 is -0.49 USD. In the previous year, EBITDA per Share was -0.74 USD — a change of -33.65% (higher).

EBITDA per Share

-0.49USD

YoY

-33.65%

Last updated:

EBITDA per Share of Quantum-Si is 2025 -0.49 USD. EBITDA per Share of Quantum-Si was 2024 -0.74 USD. It decreases by -33.65% higher compared to the previous year.

The Quantum-Si EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
-7.32 USD
Jan 1, 2020
-0.27 USD
Jan 1, 2021
-0.71 USD
Jan 1, 2022
-0.82 USD
Jan 1, 2023
-0.79 USD
Jan 1, 2024
-0.74 USD
Jan 1, 2025
-0.49 USD
The Quantum-Si EBITDA per Share history
YEAREBITDA per ShareYoY
-0.49USD-33.65%
-0.74USD-5.51%
-0.79USD-3.97%
-0.82USD+15.91%
-0.71USD+162.27%
-0.27USD-96.33%
-7.32USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quantum-Si Stock analysis

What does Quantum-Si do? Quantum-Si, Inc. generates revenue through its proprietary universal single-molecule detection platform for Next-Generation Protein Sequencing (NGPS). The company sells hardware components including the Carbon automated sample preparation instrument and the Platinum NGPS instrument, along with consumables like reagent kits and chips. Its Quantum-Si Cloud software service provides cloud-based integration for data management. The primary buyers are research institutions and biotechnology companies seeking advanced protein sequencing capabilities. These segments value the end-to-end solution that combines hardware, consumables, and software to enable massively parallel protein sequencing. The Carbon instrument is designed for sample preparation using single-use fluidics cartridges, targeting applications requiring simplicity and scalability. The Platinum NGPS instrument aims to make single-molecule detection broadly accessible, appealing to organizations needing high-throughput protein analysis. Quantum-Si Cloud integrates cloud-based solutions for seamless data handling, supporting customers in managing complex sequencing workflows. The company's products serve research-focused segments within the biotechnology industry, emphasizing innovation in protein sequencing technology. Quantum-Si's revenue streams include sales of instruments, consumables, and cloud software subscriptions. The Carbon and Platinum instruments are sold as standalone hardware solutions, while reagent kits and chips are recurring consumable purchases. The Quantum-Si Cloud service offers subscription-based access to its integrated cloud platform, ensuring continuous revenue from software services. This diversified approach caters to both initial equipment purchases and ongoing operational needs of its customers. Quantum-Si is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quantum-Si stock

EBITDA per Share of Quantum-Si is -0.49 USD in 2025.

EBITDA per Share of Quantum-Si changed from -0.74 USD to -0.49 USD, representing a -33.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Quantum-Si since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Quantum-Si

All Key Metrics — Quantum-Si